Mackenzie Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Mackenzie Financial’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-24,950	Closed	-$70K	–	1188
2020 Q1	$70K	Buy	+24,950	New	+$80.4K	﹤0.01%	1038
2019 Q4	–	Sell	-36,000	Closed	-$78K	–	1192
2019 Q3	$78K	Hold	36,000	–	–	﹤0.01%	988
2019 Q2	$113K	Sell	36,000 -4,050	-10%	-$13.1K	﹤0.01%	1067
2019 Q1	$149K	Hold	40,050	–	–	﹤0.01%	1191
2018 Q4	$116K	Hold	40,050	–	–	﹤0.01%	1113
2018 Q3	$105K	Buy	40,050 +22,650	+130%	+$55.6K	﹤0.01%	1086
2018 Q2	$41K	Sell	17,400 -4,948,362	-100%	-$13.8M	﹤0.01%	998
2018 Q1	$14.6M	Buy	4,965,762 +112,400	+2%	+$307K	0.04%	275
2017 Q4	$13.3M	Sell	4,853,362 -220,653	-4%	-$678K	0.03%	310
2017 Q3	$17.2M	Buy	5,074,015 +1,423,471	+39%	+$3.96M	0.09%	198
2017 Q2	$9.02M	Sell	3,650,544 -1,168,065	-24%	-$2.69M	0.05%	257
2017 Q1	$10.9M	Buy	4,818,609 +130,784	+3%	+$289K	0.06%	229
2016 Q4	$9.94M	Sell	4,687,825 -1,112,986	-19%	-$3.11M	0.06%	232
2016 Q3	$19.4M	Buy	5,800,811 +738,986	+15%	+$2.35M	0.12%	166
2016 Q2	$15.9M	Buy	5,061,825 +1,611,647	+47%	+$5.37M	0.09%	208
2016 Q1	$11.5M	Buy	3,450,178 +590,578	+21%	+$1.84M	0.1%	192
2015 Q4	$10.1M	Buy	+2,859,600	New	+$12M	0.06%	241

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Mackenzie Financial's PDLI Position: Q2 2020 in Review

Mackenzie Financial sold out of PDL BioPharma, Inc. (PDLI) in Q2 2020, closing a stake of 24,950 shares — an estimated $70K sold.

Mackenzie Financial first reported a position in PDLI in Q4 2015 and held it in 17 quarters. The position peaked at $19.4M in Q3 2016. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.

Mackenzie Financial reported no remaining PDL BioPharma, Inc. position as of Q2 2020 after selling out during the quarter.
Mackenzie Financial sold 24,950 PDL BioPharma, Inc. shares in Q2 2020, an estimated $70K.
Mackenzie Financial first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 17 quarters.
Mackenzie Financial's PDL BioPharma, Inc. position peaked at $19.4M in Q3 2016.
136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.

Based on Mackenzie Financial's 13F filing for Q2 2020, filed 13 Aug 2020.